Pets Antibiotic Treatment Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511248471

Publication Date:

November 18, 2024

Pages:

117

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Antibiotics are used to treat or prevent some types of bacterial infection. They kill bacteria or prevent them from reproducing and spreading. Antibiotics aren't effective against viral infections.
The global market for Pets Antibiotic Treatment Solutions was estimated to be worth US$ 239 million in 2023 and is forecast to a readjusted size of US$ 311.8 million by 2030 with a CAGR of 4.1% during the forecast period 2024-2030
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 39%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pets Antibiotic Treatment Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pets Antibiotic Treatment Solutions by region & country, by Type, and by Application.
The Pets Antibiotic Treatment Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Antibiotic Treatment Solutions.
Market Segmentation
By Company
Merck
Elanco
Zoetis
Virbac
Dechra Veterinary Products
Ceva Sant茅 Animale
Vetoquinol
Nanjing Jindun Animal
Bimeda Animal Health
Ouro Fino Saude
Segment by Type:
External Rubbing Treatment
Oral Treatment
Injection Therapy
Segment by Application
Pets Dog
Pets Cat
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pets Antibiotic Treatment Solutions manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pets Antibiotic Treatment Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pets Antibiotic Treatment Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Pets Antibiotic Treatment Solutions Product Introduction
1.2 Global Pets Antibiotic Treatment Solutions Market Size Forecast
1.3 Pets Antibiotic Treatment Solutions Market Trends & Drivers
1.3.1 Pets Antibiotic Treatment Solutions Industry Trends
1.3.2 Pets Antibiotic Treatment Solutions Market Drivers & Opportunity
1.3.3 Pets Antibiotic Treatment Solutions Market Challenges
1.3.4 Pets Antibiotic Treatment Solutions Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pets Antibiotic Treatment Solutions Players Revenue Ranking (2023)
2.2 Global Pets Antibiotic Treatment Solutions Revenue by Company (2019-2024)
2.3 Key Companies Pets Antibiotic Treatment Solutions Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pets Antibiotic Treatment Solutions Product Offered
2.5 Key Companies Time to Begin Mass Production of Pets Antibiotic Treatment Solutions
2.6 Pets Antibiotic Treatment Solutions Market Competitive Analysis
2.6.1 Pets Antibiotic Treatment Solutions Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pets Antibiotic Treatment Solutions Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Antibiotic Treatment Solutions as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 External Rubbing Treatment
3.1.2 Oral Treatment
3.1.3 Injection Therapy
3.2 Global Pets Antibiotic Treatment Solutions Sales Value by Type
3.2.1 Global Pets Antibiotic Treatment Solutions Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pets Antibiotic Treatment Solutions Sales Value, by Type (2019-2030)
3.2.3 Global Pets Antibiotic Treatment Solutions Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pets Dog
4.1.2 Pets Cat
4.1.3 Others
4.2 Global Pets Antibiotic Treatment Solutions Sales Value by Application
4.2.1 Global Pets Antibiotic Treatment Solutions Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pets Antibiotic Treatment Solutions Sales Value, by Application (2019-2030)
4.2.3 Global Pets Antibiotic Treatment Solutions Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pets Antibiotic Treatment Solutions Sales Value by Region
5.1.1 Global Pets Antibiotic Treatment Solutions Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pets Antibiotic Treatment Solutions Sales Value by Region (2019-2024)
5.1.3 Global Pets Antibiotic Treatment Solutions Sales Value by Region (2025-2030)
5.1.4 Global Pets Antibiotic Treatment Solutions Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
5.2.2 North America Pets Antibiotic Treatment Solutions Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
5.3.2 Europe Pets Antibiotic Treatment Solutions Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
5.4.2 Asia Pacific Pets Antibiotic Treatment Solutions Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
5.5.2 South America Pets Antibiotic Treatment Solutions Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
5.6.2 Middle East & Africa Pets Antibiotic Treatment Solutions Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pets Antibiotic Treatment Solutions Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pets Antibiotic Treatment Solutions Sales Value
6.3 United States
6.3.1 United States Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.3.2 United States Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.4.2 Europe Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.5.2 China Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.6.2 Japan Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.7.2 South Korea Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.8.2 Southeast Asia Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pets Antibiotic Treatment Solutions Sales Value, 2019-2030
6.9.2 India Pets Antibiotic Treatment Solutions Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pets Antibiotic Treatment Solutions Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Profile
7.1.2 Merck Main Business
7.1.3 Merck Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.1.4 Merck Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.1.5 Merck Recent Developments
7.2 Elanco
7.2.1 Elanco Profile
7.2.2 Elanco Main Business
7.2.3 Elanco Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.2.4 Elanco Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.2.5 Elanco Recent Developments
7.3 Zoetis
7.3.1 Zoetis Profile
7.3.2 Zoetis Main Business
7.3.3 Zoetis Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.3.4 Zoetis Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.3.5 Virbac Recent Developments
7.4 Virbac
7.4.1 Virbac Profile
7.4.2 Virbac Main Business
7.4.3 Virbac Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.4.4 Virbac Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.4.5 Virbac Recent Developments
7.5 Dechra Veterinary Products
7.5.1 Dechra Veterinary Products Profile
7.5.2 Dechra Veterinary Products Main Business
7.5.3 Dechra Veterinary Products Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.5.4 Dechra Veterinary Products Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.5.5 Dechra Veterinary Products Recent Developments
7.6 Ceva Sant茅 Animale
7.6.1 Ceva Sant茅 Animale Profile
7.6.2 Ceva Sant茅 Animale Main Business
7.6.3 Ceva Sant茅 Animale Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.6.4 Ceva Sant茅 Animale Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.6.5 Ceva Sant茅 Animale Recent Developments
7.7 Vetoquinol
7.7.1 Vetoquinol Profile
7.7.2 Vetoquinol Main Business
7.7.3 Vetoquinol Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.7.4 Vetoquinol Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.7.5 Vetoquinol Recent Developments
7.8 Nanjing Jindun Animal
7.8.1 Nanjing Jindun Animal Profile
7.8.2 Nanjing Jindun Animal Main Business
7.8.3 Nanjing Jindun Animal Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.8.4 Nanjing Jindun Animal Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.8.5 Nanjing Jindun Animal Recent Developments
7.9 Bimeda Animal Health
7.9.1 Bimeda Animal Health Profile
7.9.2 Bimeda Animal Health Main Business
7.9.3 Bimeda Animal Health Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.9.4 Bimeda Animal Health Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.9.5 Bimeda Animal Health Recent Developments
7.10 Ouro Fino Saude
7.10.1 Ouro Fino Saude Profile
7.10.2 Ouro Fino Saude Main Business
7.10.3 Ouro Fino Saude Pets Antibiotic Treatment Solutions Products, Services and Solutions
7.10.4 Ouro Fino Saude Pets Antibiotic Treatment Solutions Revenue (US$ Million) & (2019-2024)
7.10.5 Ouro Fino Saude Recent Developments
8 Industry Chain Analysis
8.1 Pets Antibiotic Treatment Solutions Industrial Chain
8.2 Pets Antibiotic Treatment Solutions Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pets Antibiotic Treatment Solutions Sales Model
8.5.2 Sales Channel
8.5.3 Pets Antibiotic Treatment Solutions Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck
Elanco
Zoetis
Virbac
Dechra Veterinary Products
Ceva Sant茅 Animale
Vetoquinol
Nanjing Jindun Animal
Bimeda Animal Health
Ouro Fino Saude

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂